52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer.
52 North Health has raised $350K in total funding. The most recent round was Grant. The last funding was announced in September 2025.
52 North Health's investors include Future Planet Capital, Innovate UK, Cedars Sinai, Cambridge Enterprise Ventures, NATO DIANA.
52 North Health is headquartered in Cambridge, United Kingdom.
52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer.
52 North Health is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"52 North Health — Funding & Investors." VCBacked, September 4, 2025, https://www.vcbacked.co/company/52-north-health. Accessed August 14, 2026.
VCBacked. (2025). 52 North Health — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/52-north-health
{{cite web |title=52 North Health — Funding & Investors |url=https://www.vcbacked.co/company/52-north-health |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated